Oligonucleotide compositions and methods for treating disease including inflammatory conditions

Details for Australian Patent Application No. 2004275903 (hide)

Owner Topigen Pharmaceutique Inc.

Inventors D'Anjou, Helene; Renzi, Paolo; Zemzoumi, Khalid

Agent Davies Collison Cave

Pub. Number AU-B-2004275903

PCT Pub. Number WO2005/030787

Priority 60/507,016 29.09.03 US

Filing date 29 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 12 April 2012

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030787 Priority application(s): WO2005/030787

28 September 2006 Amendment Made

  The nature of the amendment is: Amend the co-inventor from Renzie, Paolo to Renzi, Paolo

12 April 2012 Application Accepted

  Published as AU-B-2004275903

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275928-Melanocortin receptor agonists

2004275900-High alcohol content gel-like and foaming compositions